Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst

Phagocytosis and oxidative burst, induced through Rac GTPases and Toll-like receptors (TLRs), are central innate immune responses involved in inflammatory bowel disease (IBD) and colorectal cancer (CRC). However, their regulation in macrophages and involvement in colonic inflammation remain poorly characterized. We investigated Schlafen4 (Slfn4) using global and macrophage-specific Slfn4-deficient mice subjected to dextran sodium sulfate (DSS)-induced colitis and colitis-associated colorectal cancer (CAC). Gut microbiota alterations were assessed by 16S rRNA sequencing, fecal microbiota transplantation (FMT), and co-housing. Macrophage phagocytosis, ROS production, bacterial clearance, F-actin organization, and Rac1 activation were examined to define the underlying mechanism. We demonstrate that the upregulation of Slfn4 in macrophages upon TLR stimulation or bacterial infection is crucial for maintaining intestinal immune homeostasis. Global and macrophage-specific Slfn4 depletion exacerbated DSS-induced colitis and CAC, accompanied by gut microbiota dysbiosis. FMT and co-housing further supported the contribution of altered microbiota to aggravated colitis. Mechanistically, Slfn4 interacted with and activated Rac1 to remodel F-actin organization, thereby enhancing phagocytosis, ROS production, and bacterial clearance. Consequently, Slfn4-deficient macrophages exhibited impaired phagocytic and bactericidal activities, associated with disrupted barrier integrity and intestinal homeostasis. Notably, the Rac1 inhibitor NSC23766 counteracted the effects of Slfn4 deficiency. Slfn4 is an inducible regulator of macrophage innate immunity that promotes Rac1-dependent phagocytosis, ROS production, and bacterial clearance, thereby maintaining gut microbiota and intestinal homeostasis. Slfn4 protects against colitis and CAC and may represent a potential therapeutic target for IBD. Inflammatory bowel disease (IBD) causes chronic inflammation in the intestine and is closely associated with changes in gut bacteria. Macrophages are immune cells that protect the intestine by engulfing and killing harmful bacteria, but how this process is controlled remains unclear. In this study, we found that a protein called Schlafen4 (Slfn4) helps macrophages eliminate bacteria and maintain intestinal health. Mice lacking Slfn4 developed more severe intestinal inflammation and colitis-associated colorectal cancer, together with greater disruption of their gut bacteria. We found that Slfn4 activates Rac1, which helps macrophages engulf bacteria and produce reactive oxygen species needed for bacterial killing. Without Slfn4, these antibacterial functions were impaired, allowing intestinal microbial imbalance to worsen. Our findings reveal a previously unrecognized role for Slfn4 in linking macrophage antibacterial defense with gut microbiota homeostasis and suggest that this pathway may provide new opportunities for understanding and treating IBD.

Authors

Institutions

Publication Details

Journal
Communications Medicine
Published
2026-11-17
DOI
https://doi.org/10.1038/s43856-026-02012-8
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst

Tingxuan Gu, Chune Peng, Yucong Zhao, Liangwei Duan et al.
2 links
Communications Medicine
Inflammatory Bowel Disease
article

Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst

Tingxuan Gu, Chune Peng, Yucong Zhao, Liangwei Duan, Yanting Liu, Tianzhu Chao, Jing Jia, Qianqian Zheng, Jingjing Li, Chaowei Wang, Jiansen Du, Jinsong Qi, Hui Wang, Yaoyao Wu, Jingyang Feng, Qing Guan
article en

Abstract

Phagocytosis and oxidative burst, induced through Rac GTPases and Toll-like receptors (TLRs), are central innate immune responses involved in inflammatory bowel disease (IBD) and colorectal cancer (CRC). However, their regulation in macrophages and involvement in colonic inflammation remain poorly characterized. We investigated Schlafen4 (Slfn4) using global and macrophage-specific Slfn4-deficient mice subjected to dextran sodium sulfate (DSS)-induced colitis and colitis-associated colorectal cancer (CAC). Gut microbiota alterations were assessed by 16S rRNA sequencing, fecal microbiota transplantation (FMT), and co-housing. Macrophage phagocytosis, ROS production, bacterial clearance, F-actin organization, and Rac1 activation were examined to define the underlying mechanism. We demonstrate that the upregulation of Slfn4 in macrophages upon TLR stimulation or bacterial infection is crucial for maintaining intestinal immune homeostasis. Global and macrophage-specific Slfn4 depletion exacerbated DSS-induced colitis and CAC, accompanied by gut microbiota dysbiosis. FMT and co-housing further supported the contribution of altered microbiota to aggravated colitis. Mechanistically, Slfn4 interacted with and activated Rac1 to remodel F-actin organization, thereby enhancing phagocytosis, ROS production, and bacterial clearance. Consequently, Slfn4-deficient macrophages exhibited impaired phagocytic and bactericidal activities, associated with disrupted barrier integrity and intestinal homeostasis. Notably, the Rac1 inhibitor NSC23766 counteracted the effects of Slfn4 deficiency. Slfn4 is an inducible regulator of macrophage innate immunity that promotes Rac1-dependent phagocytosis, ROS production, and bacterial clearance, thereby maintaining gut microbiota and intestinal homeostasis. Slfn4 protects against colitis and CAC and may represent a potential therapeutic target for IBD. Inflammatory bowel disease (IBD) causes chronic inflammation in the intestine and is closely associated with changes in gut bacteria. Macrophages are immune cells that protect the intestine by engulfing and killing harmful bacteria, but how this process is controlled remains unclear. In this study, we found that a protein called Schlafen4 (Slfn4) helps macrophages eliminate bacteria and maintain intestinal health. Mice lacking Slfn4 developed more severe intestinal inflammation and colitis-associated colorectal cancer, together with greater disruption of their gut bacteria. We found that Slfn4 activates Rac1, which helps macrophages engulf bacteria and produce reactive oxygen species needed for bacterial killing. Without Slfn4, these antibacterial functions were impaired, allowing intestinal microbial imbalance to worsen. Our findings reveal a previously unrecognized role for Slfn4 in linking macrophage antibacterial defense with gut microbiota homeostasis and suggest that this pathway may provide new opportunities for understanding and treating IBD.

Communications Medicine
Zhengzhou University (CN), Shandong Academy of Agricultural Sciences (CN), Shangqiu First People's Hospital (CN), Zaozhuang University (CN), Henan Medical University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Higher Education Discipline Innovation Project
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon